InnovAge (INNV) Stock Price, News & Analysis

Company Overview

InnovAge is a healthcare services company that provides comprehensive care for older adults through the Program of All-Inclusive Care for the Elderly (PACE). Its programs are designed for individuals who are eligible for nursing-home-level care but can continue living in their homes and communities with coordinated medical and support services.

The company’s services include primary and specialty medical care, behavioral health, pharmacy services, rehabilitation, dentistry, social services, nutrition support, transportation and in-home care. InnovAge coordinates these services through interdisciplinary care teams and operates day centers where participants can receive healthcare, therapy, meals and social support.

InnovAge traces its roots to Total Longterm Care, a nonprofit PACE organization established in Colorado in 1990, and later adopted the InnovAge name as it expanded its operations. The company serves communities in Colorado and California through its PACE centers and affiliated services. InnovAge became a publicly traded company on the Nasdaq under the symbol INNV in 2021.

Key Stats

• Today's Range: $10.50 to $10.95
• 50-Day Range: $10.23 to $11.87
• 52-Week Range: $3.93 to $12.64
• Volume: 331,569 shs
• Average Volume: 247,381 shs
• Market Capitalization: $1.49 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $10.50
• Consensus Rating: Reduce

InnovAge Stock Analysis - MarketRank™

InnovAge scored higher than 20% of companies evaluated by MarketBeat, and ranked 825th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.3 / 5
• Analyst Rating: Reduce

Consensus Rating

InnovAge has received a consensus rating of Reduce. The company's average rating score is 1.75, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 2 sell ratings.

Upside/Downside

The consensus price target for InnovAge is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

InnovAge has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 11.63%

Earnings Growth

Earnings for InnovAge are expected to grow by 11.63% in the coming year, from $0.43 to $0.48 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of InnovAge is -546.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of InnovAge is -546.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

InnovAge has a P/B Ratio of 6.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

0.76% of the float of InnovAge has been sold short.

Short Interest Ratio / Days to Cover

InnovAge has a short interest ratio ("days to cover") of 5.48.

Change versus previous month

Short interest in InnovAge has recently increased by 18.08%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

InnovAge does not currently pay a dividend.

Dividend Growth

InnovAge does not have a long track record of dividend growth.

News and Social Media

• Score: 2.5 / 5
• News Sentiment: 0.04

News Sentiment

InnovAge has a news sentiment score of 0.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for InnovAge this week, compared to 2 articles on an average week.

MarketBeat Follows

1 people have added InnovAge to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, InnovAge insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.00% of the stock of InnovAge is held by insiders.

Percentage Held by Institutions

12.26% of the stock of InnovAge is held by institutions.

Company Calendar

• Last Earnings: 9/08/2026
• Today: 9/20/2026
• Next Earnings (Estimated): 11/03/2026
• Fiscal Year End: 6/30/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:INNV
• Previous Symbol: OTCMKTS:INNV
• CIK: 1834376
• Web: www.innovage.com
• Phone: 844-803-8745
• Fax: N/A
• Employees: 2,500
• Year Founded: 1990

Price Target and Rating

• Average Price Target for InnovAge: $10.50
• High Price Target: $14.00
• Low Price Target: $7.00
• Potential Upside/Downside: -3.8%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.75
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 25.40
• P/E Growth: N/A
• Net Income: -$2.54 million
• Net Margins: -0.26%
• Pretax Margin: 0.03%
• Return on Equity: -1.03%
• Return on Assets: -0.47%

Debt

• Debt-to-Equity Ratio: 0.23
• Current Ratio: 1.05
• Quick Ratio: 1.05

Sales & Book Value

• Annual Sales: $989.71 million
• Price / Sales: 1.51
• Cash Flow: $0.14 per share
• Price / Cash Flow: 76.50
• Book Value: $1.76 per share
• Price / Book: 6.20

Miscellaneous

• Outstanding Shares: 136,450,000
• Free Float: 135,086,000
• Market Cap: $1.49 billion
• Optionable: Optionable
• Beta: 0.40